Drug Information
Barbiturates are central nervous system depressants. They are used therapeutically as sedatives, hypnotics, and anticonvulsants.
Barbiturates are almost always taken orally as capsules or tablets. The effects resemble those of intoxication with alcohol. Chronic use of barbiturates leads to tolerance and physical dependence.
Short acting Barbiturates taken at 400 mg/day for 2-3 months can produce a clinically significant degree of physical dependence. Withdrawal symptoms experienced during periods of drug abstinence can be severe enough to cause death. Only a small amount (less than 5%) of most Barbiturates are excreted unaltered in the urine.
The approximate detection time limits for Barbiturates are:
Short acting (e.g. Secobarbital 100 mg PO (oral) 4.5 days
Long acting (e.g. Phenobarbital) 400 mg PO (oral) 7 days
Ready to modernize?
Schedule a custom demo of the platform to see how Origin One can dramatically streamline occupational health management for your business.
Keep up with what’s happening in occupational health
What Businesses Need from Occupational Health Software in 2026
Read now »
Origin One Achieves SOC 2 Type I Compliance – Reinforcing Our Commitment…
Read now »
nform’s breakthrough oral fluid rapid drug tests run on Origin One’s occupational…
Read now »
DEA Drug Take Back Day 2025: Uniting to Eliminate Risk, One Pill…
Read now »
DEA’s Red Ribbon Message for 2025: Life Is a Puzzle, Solve It…
Read now »
CDC Free Mind Campaign: Tackling Teen Drug Use in 2025
Read now »
Drive Sober or Get Pulled Over: No Excuses, Just Enforcement – NHTSA’s…
Read now »
The Hidden Dangers of Polydrug Use: When Adulteration Turns Risk into Crisis…
Read now »
